ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
BNP Paribas Issuance

BNP Paribas Issuance (P1HLD7)

0.00
0.00
(0.00%)
Cerrado 04 Enero 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
0.00
Volumen financiero
-
Precio Promedio Ponderado
-

P1HLD7 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
15600980.851099.4980.8521044.8672619DE
26000980.851099.4980.8521044.8672619DE

P1HLD7 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de BNP Paribas Issuance?
El precio actual de las acciones de BNP Paribas Issuance es 0.00 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de BNP Paribas Issuance?
BNP Paribas Issuance ha negociado en un rango de 0.00 € a 0.00 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WAMB26Ambromobiliare SpA
0.098 €
(96.00%)
53.83k
1NBNorthern Data AG
52.50 €
(30.76%)
34
EVAAskoll Eva SPA
0.17 €
(25.46%)
403k
WSOGESWarr Soges Group
0.115 €
(21.05%)
15k
WTFINTrevi Finanziaria Industriale Spa
0.89 €
(18.67%)
3.33k
WCOSMOFarmacosmo spa
0.0096 €
(-67.89%)
6.67k
COSMOFarmacosmo spa
0.668 €
(-22.86%)
338.93k
WTWL26TraWell Co SpA
0.22 €
(-21.43%)
600
GTGT Talent Group SpA
2.76 €
(-14.29%)
21.38k
WSGC28SG Company SpA
0.025 €
(-12.89%)
12.26k
TITTelecom Italia SpA
0.243 €
(-2.68%)
128.24M
ISPIntesa Sanpaolo Spa
3.849 €
(-0.03%)
47.15M
SPMSaipem Spa
2.717 €
(2.07%)
44.36M
ENELEnel Spa
7.023 €
(-0.03%)
20.56M
STLAMStellantis NV
12.142 €
(-3.79%)
15.65M
crescentmotor crescentmotor 3 minutos hace
Seems like a lot of silly effort for no impact on share price come Monday-Friday.

With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JP
AVXL JPM
mauismart mauismart 4 minutos hace
I just bought a. 2000 Toyota echo with over 100k miles for only $1200 and she gets over 30 miles to the gallon. I saved my avxl share
AVXL
carvajal carvajal 4 minutos hace

Brian's ties to Brazil date back to 2021.

" style="font-size: 1em"#HUMBL continues to advance. Please do not mistake silence for weakness."

 
HMBL
shortridge3w shortridge3w 5 minutos hace
Regarding the 1.8 point difference of ADAS-cog13 between dosed and placebo, the worst estimate could be done by extending the dosed curve 4 months, which would result in 1 point increase. This can be verified with the open label extension data.
AVXL
Risk Risk 5 minutos hace
Yes Golf. I Agree, Just want to get out man break even if it's a possiblility???
Happy to hear you made it back on Quantum stocks.
AFFU
TURCH TURCH 5 minutos hace
Yup have Rr and krknf if u find any others let me know!


Regards
doccjc doccjc 6 minutos hace
Wonder if we'll get an update on Monday ?
First full week of trading since the India  human trials announcement 
Positive human trial results may cause the stock to run imo .
RDGL
theorysuit theorysuit 7 minutos hace
Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval in mTNBC by FDA, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints to support full approval. A
NWBO
doccjc doccjc 8 minutos hace
Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 
RDGL
StockItOut StockItOut 11 minutos hace
Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.
XERI
againstallodds againstallodds 11 minutos hace
A/S tells you where JarHead is headed….
NBRI
blackhawks blackhawks 12 minutos hace
Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin
getmoreshares getmoreshares 12 minutos hace
.0005 next!
KATX
StockItOut StockItOut 13 minutos hace
The Note is either/or you moron.
XERI
SSKILLZ1 SSKILLZ1 13 minutos hace
Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5
ETCC VNDA
georgejjl georgejjl 13 minutos hace
Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,
AVXL
quester614 quester614 13 minutos hace
There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20
XERI
Manspider Manspider 15 minutos hace
Foolish rabbit … tricks are for kids! :-D
ASII
jay_tee jay_tee 15 minutos hace
It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA
RNVA
solong solong 15 minutos hace
Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.
SYIN
imho imho 16 minutos hace
I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,
AVXL

Su Consulta Reciente

Delayed Upgrade Clock